[go: up one dir, main page]

WO2011037976A3 - Pramipexole pharmaceutical formulations - Google Patents

Pramipexole pharmaceutical formulations Download PDF

Info

Publication number
WO2011037976A3
WO2011037976A3 PCT/US2010/049785 US2010049785W WO2011037976A3 WO 2011037976 A3 WO2011037976 A3 WO 2011037976A3 US 2010049785 W US2010049785 W US 2010049785W WO 2011037976 A3 WO2011037976 A3 WO 2011037976A3
Authority
WO
WIPO (PCT)
Prior art keywords
pramipexole
pharmaceutical formulations
manufacturing
methods
pharmaceutically acceptable
Prior art date
Application number
PCT/US2010/049785
Other languages
French (fr)
Other versions
WO2011037976A2 (en
Inventor
Snehalatha Movva
Hemanth Prakash Joshi
Pramod Kharwade
Badri Vishwanathan Narayanan
Prashanth Reddy Molugu
Prasad Vure
Ajmal Shareef Md
Nageswara Rao Vysyaraju
Prem Prakash Singh
Bhushan Subhash Yeola
Harshal Prabhakar Bhagwatwar
Original Assignee
Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Limited, Dr. Reddy's Laboratories, Inc. filed Critical Dr. Reddy's Laboratories Limited
Publication of WO2011037976A2 publication Critical patent/WO2011037976A2/en
Publication of WO2011037976A3 publication Critical patent/WO2011037976A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Aspects of the present application relate to pharmaceutical formulations comprising pramipexole or pharmaceutically acceptable salts thereof, methods for manufacturing the same, and uses thereof. Further aspects relate to stable extended release formulations for oral administration comprising pramipexole or pharmaceutically acceptable salts thereof and microcrystalline cellulose, methods for manufacturing the same, and uses thereof.
PCT/US2010/049785 2009-09-22 2010-09-22 Pramipexole pharmaceutical formulations WO2011037976A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IN2286CH2009 2009-09-22
IN2286/CHE/2009 2009-09-22
US31153410P 2010-03-08 2010-03-08
US61/311,534 2010-03-08
IN2570CH2010 2010-09-03
IN2570/CHE/2010 2010-09-03

Publications (2)

Publication Number Publication Date
WO2011037976A2 WO2011037976A2 (en) 2011-03-31
WO2011037976A3 true WO2011037976A3 (en) 2011-08-25

Family

ID=43796460

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/049785 WO2011037976A2 (en) 2009-09-22 2010-09-22 Pramipexole pharmaceutical formulations

Country Status (1)

Country Link
WO (1) WO2011037976A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011128914A2 (en) * 2010-04-15 2011-10-20 Cadila Healthcare Limited Extended release pharmaceutical compositions of pramipexole
KR101307334B1 (en) * 2010-07-02 2013-09-12 주식회사 바이오파마티스 Sustained-release pharmaceutical composition comprising pramipexole or pharmaceutically acceptable salt thereof having improved stability
WO2013034173A1 (en) 2011-09-06 2013-03-14 Synthon Bv Pramipexole extended release tablets
EP2732812A1 (en) 2012-11-15 2014-05-21 Aristo Pharma GmbH Pramipexole retard tablet formulation
CN103040781B (en) * 2013-01-04 2014-07-16 杭州朱养心药业有限公司 Pramipexole dihydrochloride tablet composition and preparation method thereof
US20170209380A1 (en) 2014-07-30 2017-07-27 Merck Patent Gmbh Directly compressible composition comprising microcrystalline cellulose
CN105796519A (en) * 2014-12-30 2016-07-27 浙江京新药业股份有限公司 Pramipexole dihydrochloride sustained-release tablet and preparation method thereof
CN106983729B (en) * 2016-01-21 2021-02-26 北京北大维信生物科技有限公司 Pramipexole sustained release tablet and preparation method thereof
CN114939112B (en) * 2017-12-28 2024-03-01 北京北大维信生物科技有限公司 Pramipexole sustained-release pharmaceutical composition, preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004010999A1 (en) * 2002-07-25 2004-02-05 Pharmacia Corporation Pramipexole once-daily dosage form
US20050226926A1 (en) * 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
WO2006046256A1 (en) * 2004-10-27 2006-05-04 Alembic Limited Extended release formulation of pramipexole dihydrochloride

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004010999A1 (en) * 2002-07-25 2004-02-05 Pharmacia Corporation Pramipexole once-daily dosage form
US20050226926A1 (en) * 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
WO2006046256A1 (en) * 2004-10-27 2006-05-04 Alembic Limited Extended release formulation of pramipexole dihydrochloride

Also Published As

Publication number Publication date
WO2011037976A2 (en) 2011-03-31

Similar Documents

Publication Publication Date Title
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
WO2012021715A3 (en) Stable formulations of linaclotide
WO2012020097A3 (en) Use of binders for manufacturing storage stable formulations
WO2009066326A3 (en) Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts
WO2009017837A3 (en) Sublingual fentanyl spray
WO2009063222A3 (en) Solid compositions
IL217052A0 (en) Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them
WO2012054831A3 (en) Ready to use ketorolac formulations
WO2011076212A3 (en) Processes for the manufacture of a pharmaceutically active agent
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2011079193A3 (en) Preparation of bendamustine and its salts
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
TN2011000651A1 (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine their preparation and their therapeutic application
WO2011019326A3 (en) Solubility and stability enchancing pharmaceutical formulation
WO2013106068A3 (en) Therapeutic compositions of specified herbal formulations and uses thereof
WO2011069076A3 (en) Sustained release donepezil formulations
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2010082220A3 (en) Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
WO2010012459A3 (en) A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
WO2011142731A3 (en) Formulations comprising a third generation cephalosporin and clavulanic acid
PL1994926T3 (en) Valsartan formulations
TR201001417A1 (en) Cefdinir formulation with improved dissolution rate
EP2196463A4 (en) Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof
WO2011101734A3 (en) Taste-masked powder for suspension compositions of methylprednisolone
WO2010148314A3 (en) Preparation of esomeprazole and its pharmaceutically acceptable salts

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10819374

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10819374

Country of ref document: EP

Kind code of ref document: A2